Compound ID | 785
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | RNA synthesis inhibitor. RNA polymerase inhibitor |
| Target Pathogen: | Broad spectrum activity including Mycobacterium sp. |
| Description: | Natural product from Sorangium cellulosum |
| Institute where first reported: | Ciba-Geigy (Novartis, Switzerland) |
| Year first mentioned: | 1986 |
| Development status: | Experimental |
| Reason dropped: | Demonstrates partial cross resistance with rifamycin's due to partial overlap in binding site but has 'potential promise as an antituberculosis agent effective against a subset of rifamycin-resistant bacterial infections' |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/657059 |
| Guide to Pharmacology: | sorangicin A |
| Citations: |
|